<DOC>
	<DOC>NCT01390246</DOC>
	<brief_summary>This is a prospective, double-blind placebo-controlled randomized controlled trial of the preliminary safety and efficacy of bupropion SR in combination with behavioral counseling for smoking cessation during pregnancy.</brief_summary>
	<brief_title>Bupropion for Smoking Cessation During Pregnancy</brief_title>
	<detailed_description>This is a prospective, double-blind placebo-controlled randomized controlled trial of the preliminary safety and efficacy of bupropion SR in combination with behavioral counseling for smoking cessation during pregnancy. A total of 150 pregnant smokers will receive medication (75) or placebo (75) for 12 weeks. Compassionate care/continuance of therapy will be available to pregnant subjects. Women who relapse to smoking postpartum will be offered an additional course of medication treatment. All subjects irregardless of adherence with 12 week study drug administration period and smoking habits during pregnancy will be followed through the duration of their pregnancy, delivery, and 6-month post partum period. Subject participation will begin between 13-26 wks of gestation and end 6 months postpartum. Participation will be ten (10) to thirteen(13)months in length.</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>smoking at least 10 CPD prior to pregnancy and 5 CPD for the preceding 7 days 1326 weeks gestation â‰¥18 years of age able to speak English or Spanish intent to carry pregnancy to term stable residence. current illicit drug or alcohol abuse or dependence twins or other multiple gestation treatment for psychiatric disorder within the last 6 months unstable medical problems (eg, hypertension (BP&gt;140/90), preeclampsia, threatened abortion, hyperemesis gravidarum) known congenital abnormality seizure disorder use of psychotropic medication use of medication known to lower the seizure threshold anorexia/bulimia a personal history of closed head trauma with &gt; 30 minutes of loss of consciousness or amnesia or resulting in skull fracture or subdural hematoma/brain contusion use of any other smoking cessation treatment in the past 30 days current enrollment in methadone treatment program</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Pregnancy</keyword>
	<keyword>Tobacco use disorder</keyword>
	<keyword>Smoking cessation</keyword>
	<keyword>Bupropion SR</keyword>
	<keyword>Zyban</keyword>
</DOC>